NDC 0149-0734-02 - Dantrium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0149-0734
- Requested NDC
- 0149-0734-02
- Package NDCs from labels
- 0149-0734-02
- Manufacturer
- Procter and Gamble Pharmaceuticals
- Effective date
- 2006-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dantrium - Procter and Gamble Pharmaceuticals | Procter and Gamble Pharmaceuticals | 2006-02-06 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| dantrolene sodium | ACTIVE INGREDIENT | 287M0347EV | DANTRIUM (DANTROLENE SODIUM) INJECTION [PROCTER AND GAMBLE PHARMACEUTICALS] | 2 | |
| dantrolene | ACTIVE MOIETY | F64QU97QCR | DANTRIUM (DANTROLENE SODIUM) INJECTION [PROCTER AND GAMBLE PHARMACEUTICALS] | 2 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | DANTRIUM (DANTROLENE SODIUM) INJECTION [PROCTER AND GAMBLE PHARMACEUTICALS] | 2 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | DANTRIUM (DANTROLENE SODIUM) INJECTION [PROCTER AND GAMBLE PHARMACEUTICALS] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AD57FBC5-DC8E-439B-9E56-099DF3B246B0 | ef4d3d9f-4976-4eae-92b1-77749de3c63c | 2006-02-06 | Warnings, Adverse reactions | AD57FBC5-DC8E-439B-9E56-099DF3B246B0 ef4d3d9f-4976-4eae-92b1-77749de3c63c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.